Alveolar Microlithiasis

Symptoms

Common signs and symptoms of Alveolar Microlithiasis include:

Gradual shortness of breath during physical activity

Dry, persistent cough that doesn't respond to usual treatments

Chest pain or tightness, especially during exertion

Fatigue and reduced exercise tolerance over time

Bluish discoloration of lips or fingernails during activity

Clubbing of fingers and toes in advanced cases

Rapid, shallow breathing patterns

Feeling of chest heaviness or pressure

Reduced ability to take deep breaths

Progressive weakness during daily activities

When to see a doctor

If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.

Causes & Risk Factors

Several factors can contribute to Alveolar Microlithiasis.

The primary cause of alveolar microlithiasis lies in genetic mutations affecting the SLC34A2 gene, which provides instructions for making a protein called sodium-phosphate cotransporter.

The primary cause of alveolar microlithiasis lies in genetic mutations affecting the SLC34A2 gene, which provides instructions for making a protein called sodium-phosphate cotransporter. This protein normally helps clear phosphate from the lungs. When mutations disrupt this process, calcium phosphate crystals begin accumulating in the alveoli, the tiny air sacs where oxygen exchange occurs.

These microscopic stones form gradually as the body's natural cleaning mechanisms fail to remove excess minerals from lung tissue.

These microscopic stones form gradually as the body's natural cleaning mechanisms fail to remove excess minerals from lung tissue. The process resembles how kidney stones develop, except these deposits form throughout millions of alveoli simultaneously. The calcium phosphate microliths typically measure between 0.01 and 3 millimeters and can number in the millions within affected lungs.

While most cases result from inherited genetic mutations passed down through families in an autosomal recessive pattern, some individuals develop the condition without any known family history.

While most cases result from inherited genetic mutations passed down through families in an autosomal recessive pattern, some individuals develop the condition without any known family history. Researchers continue studying whether environmental factors or other genetic variations might contribute to these sporadic cases, though the fundamental mechanism appears to involve disrupted phosphate metabolism within lung tissue.

Risk Factors

Family history of alveolar microlithiasis or related genetic mutations
Parents who are carriers of SLC34A2 gene mutations
Consanguineous marriage in family history (marriage between relatives)
Mediterranean, Middle Eastern, or Turkish ancestry
Previous unexplained lung problems in family members
Chronic kidney disease affecting phosphate metabolism

Diagnosis

How healthcare professionals diagnose Alveolar Microlithiasis:

1
Diagnosing alveolar microlithiasis often begins when doctors notice characteristic findings on chest X-rays performed for other reasons.
Diagnosing alveolar microlithiasis often begins when doctors notice characteristic findings on chest X-rays performed for other reasons. The imaging shows a distinctive "sandstorm" or "ground glass" pattern caused by millions of tiny calcium deposits throughout both lungs. High-resolution CT scans provide even more detailed views, revealing the extent and distribution of microliths with remarkable clarity.
2
Pulmonary function tests help assess how the condition affects breathing capacity and gas exchange.
Pulmonary function tests help assess how the condition affects breathing capacity and gas exchange. These tests typically show restrictive patterns, meaning the lungs become stiffer and hold less air than normal. Doctors may also perform arterial blood gas analysis to measure oxygen and carbon dioxide levels, especially during exercise testing to evaluate functional limitations.
3
Genetic testing can confirm the diagnosis by identifying mutations in the SLC34A2 gene.
Genetic testing can confirm the diagnosis by identifying mutations in the SLC34A2 gene. This testing also helps identify family members who might be carriers or at risk. In some cases, doctors may recommend lung biopsy to examine tissue samples directly, though the characteristic imaging findings often make this unnecessary. Bronchoalveolar lavage, a procedure that washes cells from the lungs, can reveal the presence of microliths under microscopic examination.

Complications

Progressive respiratory failure represents the most serious complication of alveolar microlithiasis as the accumulating microliths gradually impair the lungs' ability to exchange oxygen and carbon dioxide effectively.
This process typically occurs over many years, though the rate varies significantly among individuals.
Some people maintain relatively stable function for decades, while others experience more rapid decline requiring intervention.
Secondary complications can include pulmonary hypertension, where increased pressure develops in the blood vessels of the lungs due to the mechanical obstruction caused by widespread microliths.
This can strain the right side of the heart over time.
Respiratory infections pose particular risks, as the compromised lung architecture makes it harder for the body to clear bacteria and other pathogens effectively.
Pneumothorax, or collapsed lung, can occur though it's relatively uncommon compared to other interstitial lung diseases.

Prevention

Since alveolar microlithiasis results from inherited genetic mutations, traditional prevention methods don't apply to those who already carry the genetic changes.
However, genetic counseling plays a vital role in family planning decisions for affected individuals and their relatives.
Couples with family histories of the condition can undergo genetic testing to determine their carrier status and understand the risks of passing the condition to children.
For families with known genetic mutations, prenatal testing can detect the condition in developing babies.
This information helps parents prepare for specialized care and monitoring if needed.
While this doesn't prevent the condition, early awareness allows for prompt medical attention and appropriate management from the beginning.
People diagnosed with alveolar microlithiasis can take steps to protect their remaining lung function and potentially slow progression.
These include avoiding smoking and secondhand smoke exposure, staying current with vaccinations (especially pneumonia and flu vaccines), maintaining good overall health through proper nutrition and exercise within their limitations, and promptly treating any respiratory infections that develop.

Treatment Approaches

Currently, no specific treatment can reverse or halt the progression of alveolar microlithiasis, making supportive care the cornerstone of management.

Currently, no specific treatment can reverse or halt the progression of alveolar microlithiasis, making supportive care the cornerstone of management. Treatment focuses on maintaining lung function, managing symptoms, and preventing complications as the disease progresses. Pulmonary rehabilitation programs help patients maintain physical fitness and learn breathing techniques to optimize remaining lung capacity.

Oxygen therapy becomes necessary as the condition advances and gas exchange becomes impaired.

Oxygen therapy becomes necessary as the condition advances and gas exchange becomes impaired. Many patients eventually require supplemental oxygen during activities or continuously as the disease progresses. Bronchodilators may provide some symptom relief, though their effectiveness varies among individuals. Some doctors prescribe medications to prevent respiratory infections, which can be particularly dangerous for people with compromised lung function.

MedicationTherapy

Lung transplantation represents the only definitive treatment for end-stage disease.

Lung transplantation represents the only definitive treatment for end-stage disease. Patients typically become candidates for transplantation when their lung function deteriorates significantly and quality of life becomes severely impaired. The timing of transplant evaluation requires careful consideration, as the disease progression varies widely among individuals. Some patients maintain stable function for decades, while others experience more rapid decline.

Researchers are investigating potential treatments targeting the underlying phosphate metabolism dysfunction.

Researchers are investigating potential treatments targeting the underlying phosphate metabolism dysfunction. Early studies examine medications that might influence calcium phosphate crystal formation or enhance the body's ability to clear existing deposits. Gene therapy approaches are also being explored, though these remain in experimental stages and are not yet available for clinical use.

MedicationTherapy

Living With Alveolar Microlithiasis

Managing daily life with alveolar microlithiasis requires adapting to gradual changes in breathing capacity while maintaining as much normalcy as possible. Regular monitoring with pulmonary function tests and imaging helps track disease progression and guide treatment adjustments. Many people find that pacing activities and using energy conservation techniques helps them accomplish daily tasks without excessive fatigue.

Staying physically active within individual limitations helps maintain cardiovascular fitness and muscle strength.Staying physically active within individual limitations helps maintain cardiovascular fitness and muscle strength. Pulmonary rehabilitation programs teach breathing exercises, proper use of oxygen equipment when needed, and strategies for managing shortness of breath. Support groups, whether in-person or online, provide valuable connections with others facing similar challenges, though the rarity of the condition means finding others locally can be difficult.

Emotional support plays a crucial role in coping with a progressive lung disease.Emotional support plays a crucial role in coping with a progressive lung disease. Many people benefit from counseling or therapy to process the psychological aspects of living with a chronic condition. Planning for the future, including discussions about advanced care preferences and potential lung transplantation, helps reduce anxiety and ensures that medical care aligns with personal values and goals. Family education about the condition helps loved ones provide appropriate support and understand what to expect as the disease progresses.

Latest Medical Developments

Latest medical developments are being researched.

Frequently Asked Questions

Is alveolar microlithiasis contagious or can it spread to others?

No, alveolar microlithiasis is not contagious and cannot spread between people. It's a genetic condition caused by inherited mutations, not an infection or environmental exposure that others can catch.

Can I still exercise safely with this condition?

Exercise is generally encouraged within your individual limitations, though you should work with your healthcare team to determine safe activity levels. Pulmonary rehabilitation can help you learn how to exercise effectively while managing any breathing difficulties.

Will my children definitely inherit this condition?

Not necessarily. Since alveolar microlithiasis follows an autosomal recessive inheritance pattern, children need to inherit mutations from both parents to develop the condition. Genetic counseling can help you understand the specific risks for your family.

How quickly does the condition typically progress?

Disease progression varies widely among individuals. Some people maintain stable lung function for decades, while others experience more noticeable changes over years. Regular monitoring helps track any changes in your specific case.

Are there any dietary changes that might help?

Currently, no specific diet has been proven to affect the progression of alveolar microlithiasis. However, maintaining good overall nutrition supports general health and may help you maintain strength and energy as you manage the condition.

When might I need to consider lung transplantation?

Lung transplantation is typically considered when lung function deteriorates significantly and quality of life becomes severely impaired. Your healthcare team will monitor your condition over time and discuss this option if and when it becomes appropriate.

Can pregnancy be safely managed with this condition?

Pregnancy can often be managed safely, though it requires close monitoring by specialists familiar with both the lung condition and high-risk pregnancy care. The increased demands on the respiratory system during pregnancy need careful evaluation.

Are there any medications I should avoid?

Your doctor will review all medications to ensure they're safe for someone with compromised lung function. Some sedating medications or those that suppress breathing might need to be avoided or used with caution.

Will I eventually need oxygen therapy?

Many people with alveolar microlithiasis do eventually require supplemental oxygen, though the timing varies greatly. Some need it only during activities or sleep, while others may require continuous oxygen as the condition progresses.

Can other family members be tested for the genetic mutation?

Yes, genetic testing can identify family members who carry mutations for alveolar microlithiasis. This information can be valuable for family planning decisions and helps relatives understand their risk of having affected children.

Update History

May 7, 2026v1.0.0

Published by DiseaseDirectory